Drug development

#ADME / Tox #Drug development #Drug discovery #Regulatory #Webinar

Register now: Why are ADME and DDI investigations important?

Join DDW for this exclusive free event, Are in vitro metabolism and drug-drug interaction studies critical for an investigational new drug application? which is supported by BioIVT. Expert Dr Andrew G Taylor, PhD, ADME Technical Sales Specialist, BioIVT, will present this event which will take place… Read More

Webinar date:
Supported by BioIVT
#News

Medical research
#ADME / Tox #Drug development #Drug discovery #Regulatory #Webinar

ADME and DDI considerations during drug development

Join DDW for this exclusive free event, Are in vitro metabolism and drug-drug interaction studies critical for an investigational new drug application? which is supported by BioIVT. Expert Dr Andrew G Taylor, PhD, ADME Technical Sales Specialist, BioIVT, will present this event which will take place… Read More

Webinar date:
Supported by BioIVT
#News

#Drug development #Drug discovery #Generics #Regulatory

Pioneering access to complex generic products 

Claire D’Abreu-Hayling, Chief Scientific Officer at Sandoz, examines how generic products can relieve industry pressure and improve access to essential medicines.   Off-patent medicines today account for about 80% of global prescriptions at an estimated 20% of the total cost. This will continue to be the case going forward, but the nature… Read More

#Exclusive Content

Medical researcher
#ADME / Tox #Drug development #Drug discovery #Regulatory #Webinar

ADME and DDI considerations during drug development

Join DDW for this exclusive free event, Are in vitro metabolism and drug-drug interaction studies critical for an investigational new drug application? which is supported by BioIVT. Expert Dr Andrew G Taylor, PhD, ADME Technical Sales Specialist, BioIVT, will present this event which will take place… Read More

Webinar date:
Supported by BioIVT
#News

Regulatory concept
#AI / data analytics / healthtech / informatics #Digitalisation #Drug development #Regulatory

Reflections on life science’s regulatory environment  

In this article, Amplexor asks some of the company’s closest industry partners and BE THE EXPERT event speakers for their views on the biggest developments in the Life Sciences Regulatory sphere over the last 12 months - and explore some of the most prominent themes and priorities seen throughout 2023.  … Read More

#Exclusive Content

Medical research
#ADME / Tox #Drug development #Drug discovery #Regulatory #Webinar

Learn about ADME and DDI considerations in drug discovery

Join DDW for this exclusive free event, Are in vitro metabolism and drug-drug interaction studies critical for an investigational new drug application? which is supported by BioIVT. Expert Dr Andrew G Taylor, PhD, ADME Technical Sales Specialist, BioIVT, will present this event which will take place… Read More

Webinar date:
Supported by BioIVT
#News

Medical research
#ADME / Tox #Drug development #Drug discovery #Regulatory

Are in vitro metabolism and drug-drug interaction studies critical for an investigational new drug application?

In vitro ADME and drug-drug interaction (DDI) investigations are early activities in the drug development process that are critical for framing downstream decision making. Understanding the ADME properties and DDI risks of your compound helps you avoid unnecessary clinical studies, costs, delays and more. This webinar will provide insights at… Read More

Webinar date:
Supported by BioIVT
#Webinars

Diversity
#Clinical research #Clinical trials #Diversity #Drug development #Organoids

The importance of introducing diversity earlier in drug development 

DDW’s Reece Armstrong speaks to Shantanu Dhamija, VP of Strategy and Innovation at Molecular Devices about challenges of diversity in clinical trials and why induced pluripotent stem cells might be key to representing wider patient groups.   RA: Why is US clinical trial diversity at its lowest point in the last… Read More

#Exclusive Content

Advanced therapies
#Advanced Therapies #CAR-T #Cell and gene therapy #Drug development

Commercialising advanced therapies: Industry perspectives 

Dr Christian K Schneider, Head of Biopharma Excellence at PharmaLex, presents the findings of an industry panel debate on barriers to commercialisation of novel treatments, and the most effective strategies to bring them to market.  With so many exciting novel treatments emerging from the labs, biotechs and pharma companies need… Read More

#Exclusive Content #Opinion

Genetic research
#CAR-T #Drug development #Drug discovery #Synthetic biology

Synthetic biology: Innovating in drug discovery

Listen to this article on the DDW Podcast: Synthetic biology is increasingly important to drug discovery and development. Reece Armstrong examines recent activity within the sector and highlights some of the key advancements and innovation. Partnerships Earlier this year cell-engineering company MaxCyte signed a strategic platform license (SPL) with biotechnology company… Read More

#Exclusive Content

Biologics research
#Biologics #Drug development #Drug discovery #Guide #Monoclonal antibodies #Screening

Guide: Assessing thermal stability with nanoDSF

A new Guide ‘The biologics researcher’s mini-guide to screening candidates with nanoDSF’ is now available from NanoTemper. Among the most common critical quality attributes (CQAs) for early developability assessment is thermal stability. One particular tool for assessing thermal stability with high resolution is nano-differential scanning fluorimetry (nanoDSF). Read More

#News

#Biologics #Drug development #Drug discovery #Guide #Monoclonal antibodies #Screening

The biologics researcher’s mini-guide to screening candidates with nanoDSF

Among the most common critical quality attributes (CQAs) for early developability assessment is thermal stability. One particular tool for assessing thermal stability with high resolution is nano-differential scanning fluorimetry (nanoDSF). Read this mini-guide to learn: How nanoDSF uses your protein’s intrinsic fluorescence to determine its melting temperature, Tm and onset… Read More

#Intelligence #Resources

#Drug development #Elegen #Events #mRNA #mRNA-based vaccines #Webinar

Further insight into breakthroughs in mRNA drug discovery 

DDW recently hosted Where are the breakthroughs in mRNA drug discovery and development? In this webinar, sponsored by Elegen, attendees learnt about the breakthroughs in mRNA drug discovery and development. Watch this on demand now.   Due to technical difficulties, Carsten Rudolph, Managing Director and CEO of Ethris, was unable to… Read More

#Exclusive Content

Paediatric medicine concept
#Drug development #EMA #FDA #Paediatrics #Regulatory

What recent paediatric guidelines mean for drug developers 

Justin Hay, Senior Director, Amy Cheung Senior Director of Integrated Drug Development, and Patrick Loebs Director, at Certara, examine recent changes in paediatric guidelines and how they affect drug development projects.   It has been a very busy period recently for paediatric drug development with the release of many guidance documents… Read More

#Regulatory

DDW Antibodies eBook
#Antibodies #Antibody drug conjugate (ADC) #Antibody-based therapeutics #Drug development #Drug discovery

Antibody discovery: Breakthroughs accelerating therapeutic antibodies

This 24-page eBook sponsored by Carterra examines the market for therapeutic antibodies and the breakthroughs driving drug discovery in this sector. Download this exclusive eBook to learn more about: The market for therapeutic antibodies Advancements and challenges in the sector Trends in the antibody-drug conjugate (ADC) market… Read More

#DDW eBooks #Intelligence

#Acquisition #Biopharma #Biotechnology #CDMO #Cell and gene therapy #Cold chain #Drug development #GSK #Pfizer #Regulatory #Supply chain

New podcast: A business case for drug discovery

This is the latest episode of the free DDW narrated podcast, “A business case for drug discovery”, which covers three articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “A deal in the making”, “Why project management… Read More

#News